Impera Alfa invest in innovative projects, including research & development projects, as well as new companies using unique technologies and having the so-called Polish Factor (Polski Pierwiastek).
Impera Alfa participate in building up the value of projects by supporting the creation and implementation of their development strategy and help the project providers to commercialise their product and to enter foreign markets.
The companies in which we invest have to meet the criterion of young and innovative entrepreneur, i.e. they need to devote a certain part of the budget for research and development and they have to possess the so–called Polish Factor (Polski Pierwiastek), which means that the main part of their R&D needs to be conducted in Poland. The company must not have been registered in the last 5 years.
- We cooperate with universities, research institutes and scientists.
- We address those economic entities and private individuals that are interested in the commercialisation of the results of their research and development, as well as innovative products from the industry branches listed above.
- The total investment into one project may not exceed PLN 1 million. What is important is that part of this amount is transferred as capital contributions, and the remaining part is treated as a non-reimbursable subsidy.
Our aim is to build up the value of the investment projects. Impera Alfa expert group actively supports the bodies managing the portfolio companies and B&R projects in all significant aspects of their functioning. We pay particular attention to the strategy of a given undertaking and products commercialisation, also through entering foreign markets.
for the food industry
Internet and mobile
Medicine and health
Technologies and services
for the financial industry
Technologies and services
for the advertising industry
Projects in the field of ICT infrastructure,
cloud, big data, and implemented in SaaS model
to the above-mentioned
Please send information on investment projects to the following address:
* Please fill out the form
Impera Alfa is a venture capital investment company established by Private Investors and Impera Capital S.A. in order to realise, along with The National Centre for Research and Development, a joint project under the BRIdge Alfa programme.
We invest in innovative projects, including research & development projects, as well as new companies using unique technologies and having the so-called Polish Factor (Polski Pierwiastek).
Currently, we participate in building up the value of projects by supporting the creation and implementation of their development strategy.
We help the project providers to commercialise their product and to enter foreign markets.
During his 15-year career, he was executing M&A transactions, the issue of shares of public companies as well as private companies sales to professional or financial investors.
Since 2014 he is a member of the board of Impera Capital S.A. and since 2011 he is a member of the board of Impera Seed Fund Sp. z o.o. – the entity managing the capital fund, established by Impera Capital S.A. and Krajowy Fundusz Kapitałowy S.A.
Currently, he serves on several supervisory boards in companies from the new technologies sector. He graduated from Warsaw School of Economics majoring in Finance and Banking.
Cezary Gregorczuk graduated from Warsaw School of Economics at the Faculty of Foreign Trade, majoring in Finance and Banking on an individual course of study. He attended an inter-university seminar in Hamburg on Polish-German joint venture companies. He obtains a stock broker license.
From 2004 to 2008 he worked as a Vice Director of the Brokerage House in the Brokerage House of Bank PrzemysłowoHandlowy S.A., supervising the work of the Analysis and Financial Consultancy Team, as well as the Asset Management Team.
For the last few years, he has been serving on several supervisory boards, including some public companies. He was a business angel.
NapiFeryn BioTech is a Polish start-up established in 2014 by the following scientists: Piotr Wnukowski and Magdalena Kozłowska. The team works on, innovative at the world scale, FIDOs technology which allows the possibility to obtain whey isolate from rapeseed.
NapiFeryn cooperates with prestigious scientific bodies, such as BioNano Park in Łódź (The Industrial Biotechnology Laboratory), Lodz University of Technology, Warsaw University of Life Sciences as well as the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn.
The company was established in order to provide technological and engineering support for various branches of industry, especially in the area of production.
For over a decade, Tools-Chem has been constantly developing and gaining experience, mainly in the production technology of coolants, greases, means for cleansing and disinfection as well as cooling and greasing systems. The crucial point of our offer is advisory on lubricants service, quality assurance, as well as stability of processing, but primarily we focus on improving the safety and comfort of people working with machines and tools.
LifeGel is a start-up aiming to change the way laboratory research is carried out.
The company has been developing a product allowing every laboratory to develop threedimensional cell cultures. The team believes that their product will enable scientists to carry out tests that can positively affect our everyday lives.
Impera Alfa Sp. z o.o.
Murckowska 14 A Street | Green Park
40 -265 Katowice
Phone. +48 22 378 55 50
Fax. + 48 22 378 55 51
* Please fill out the form
The National Centre for Research and Development
The National Centre for Research and Development is the implementing agency of the Minister of Science and Higher Education.
It was established in 2007 to carry out tasks within the state policies on science, innovation, as well as science and technology.
When it was opened, it was the first unit of this type, serving as a platform for dialogue between science and business sectors.
Impera Capital S.A.
An investment company listed on the Warsaw Stock Exchange. The company runs venture capital investment projects. Impera Capital S.A. focuses on IT, ITC and ecommerce industries, as well as innovative products and services.
As an experienced investor, we competently support business projects that we are engaged in.
The main goal of Impera Capital S.A. is portfolio value growth through investing in unique and innovative projects. Our strategy is based on direct investing in companies and on creating special-purpose assets with our partners.
BRIdge Alfa is addressed to projects in the seed phase, when the risk of investment failure is the highest, but it may be verified with relatively low costs.
Such projects are seen as attractive products by Venture Capital Funds. This helps to eliminate an equity gap, which stops scientists from reaching business with their projects.
Inteligentny Start (Smart Start)
The main objective of the programme is to enable young Poles studying at foreign universities to gain experience through placements and traineeships in Polish companies. The programme is also designed to facilitate overseas expansion of Polish companies, especially small- and medium–sized enterprises.
Inteligentny Start (Smart Start) programme is dedicated to:
- young Polish students at foreign universities,
- Polish graduates from foreigns universities living in the country in which they have studied,
- Polish entrepreneurs developing their companies in foreign markets.